0.1450
0.0000
(0.00%)
At close: August 1 at 9:30:00 AM EDT
Breakdown
12/31/2021
12/31/2020
Total Assets
7,610.2980
9,523.7070
Total Liabilities Net Minority Interest
3,301.5450
4,131.0730
Total Equity Gross Minority Interest
4,308.7530
5,392.6340
Total Capitalization
4,308.7530
5,820.3900
Common Stock Equity
4,308.7530
5,392.6340
Net Tangible Assets
-1,984.5840
1,303.6340
Working Capital
-2,139.1480
1,283.9700
Invested Capital
4,338.7530
5,820.3900
Tangible Book Value
-1,984.5840
1,303.6340
Total Debt
30.0000
427.7560
Share Issued
21,447.0370
11,837.8130
Ordinary Shares Number
21,447.0370
11,837.8130
12/31/2020 - 8/22/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LIANY LianBio
0.2630
0.00%
LOBEF Lobe Sciences Ltd.
0.0019
0.00%
ONCO.CN Onco-Innova
1.2000
0.00%
LOBE.CN Lobe Sciences Ltd.
0.0250
0.00%
NGEN.V NervGen Pharma Corp.
3.0900
+3.69%
EDSA Edesa Biotech, Inc.
1.7750
-1.39%
RLF.SW Relief Therapeutics Holding SA
3.8500
-1.53%
IPA ImmunoPrecise Antibodies Ltd.
0.5285
-2.85%
CYBN.NE Cybin Inc.
12.85
-7.22%
OCEA Ocean Biomedical, Inc.
0.6318
-5.43%